Ignite Creation Date:
2025-12-24 @ 5:54 PM
Ignite Modification Date:
2026-03-01 @ 5:00 PM
Study NCT ID:
NCT02124668
Status:
COMPLETED
Last Update Posted:
2024-11-21
First Post:
2014-04-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Sponsor:
Astellas Pharma Europe B.V.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
9785-CL-0122
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |